HSP90AA1 and breast carcinoma: First, MDA-MB-231 breast cancer cells restored HSP90 function in the presence of PU-H71 through an HSP90α Y142N mutation affecting the N-terminal ATP-binding pocket of HSP90α, which was accompanied by amplification and overexpression of the HSP90AA1 locus.